ClinicalTrials.gg
RecruitingNCT06920186INCAUpdated Jun 5, 2026

Infiltration or Nerve Blocks in Addition to Adductor Canal Block

An interventional study of Analgesia and Analgesia in Gonarthrosis and Total Knee Arthroplasty, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 124 studies in Osteoarthritis, Knee with a site in France — 23 open to participants now, 33 under way, 1 of them phase 3. Osteoarthritis, Knee · France.

Planned enrollment
45th of 86
100 · median 106
Started
2026
with 3 others
No phase
58 of 124
13 open now
Primary completion
2027-05
later than 19 of 32 live
Registered
116th of 124
by date
Lead sponsor
4 of 124
GCS Ramsay Santé pour l'Enseignement et la Recherche

Among the 124 studies in Osteoarthritis, Knee with a site in France, this one is the 45th largest by planned enrollment of the 86 interventional ones that give a count, is one of 4 that started in 2026, is one of 58 with no phase, reaches primary completion later than 19 of the 32 other live ones, and was the 116th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

23 of the 124 studies in Osteoarthritis, Knee with a site in France are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 124 studies in Osteoarthritis, Knee with a site in France, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the analgesic efficacy of this quadruple sensory block compared with the currently recommended procedure (adductor canal block + infiltration).

Read the detailed description

In addition to the adductor canal block, this quadruple block incorporates :

  1. the block of the lateral cutaneous nerve of the thigh (or femoral-cutaneous nerve), which is a collateral sensory branch of the posterior part of the lumbar plexus.
  2. IPACK (Infiltration between Popliteal Artery and Capsule of Knee), designed as a motor-sparing technique (targeting the sensory articular branches of the sciatic nerve and avoiding the motor branches of the tibial and fibular nerves), is particularly effective on posterior pain.
  3. obturator nerve block, a mixed nerve originating from the anterior part of the lumbar plexus. It divides into two branches: anterior, which innervates the adductor longus, adductor brevis and gracilis muscles, and posterior, which innervates the medial part of the knee joint and the posteromedial part of the thigh. It provides sensitivity to the medial aspect of the thigh.
03

Conditions studied

  • Gonarthrosis
  • Total Knee Arthroplasty
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult male or female
  • Patient with signed consent to participate in the study,
  • Patient with uni or bilateral primary gonarthrosis
  • Indication for total knee arthroplasty.

Exclusion criteria

Exclusion Criteria:

  • History of knee fracture, arthroplasty or osteotomy
  • Known or unknown to ALR or locoregional anesthesia products
  • Neurological disease, stroke sequelae
  • Mental deficiency or any other reason that may hinder understanding or strict application of the protocol
  • Patient not affiliated to the French social security system
  • Patient under court protection, guardianship or curatorship
  • Pregnant or potentially pregnant women (women of childbearing age without effective )
  • Patient already included in another therapeutic study protocol
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Sham comparator
    Group 1 of local analgesia protocol (PROSPECT recommandations)

    Locoregional analgesia (LRA) protocol n°1 : adductor canal block + surgical infiltration (PROSPECT recommendations)

    Procedure: Analgesia

  • Experimental
    Group 2 of local analgesia protocol (quadri-peripheral nerve block )

    Locoregional analgesia (LRA) protocol n° 2 : adductor canal block + femoral-cutaneous block + obturator block + IPACK block

    Procedure: Analgesia

Interventions

  • ProcedureAnalgesia

    1- Real Adductor canal block + surgical infiltration and sham of femoro-cutaneous block + obturator block + IPACK block with physiological serum

  • ProcedureAnalgesia

    2- Real Adductor canal block + femoral-cutaneous block + obturator block + IPACK block and sham of surgical infiltration with physiological serum

06

What researchers measure

Primary outcomes

  1. Patient's recovery at H24 as after surgery assessed by the QoR-15 (Quality of Recovery) questionnaire score

    The QoR-15 score at H24 after surgery was compared between the two groups for primary endpoint analysis. The QoR-15 accurately measures postoperative recovery by focusing on 5 key domains: pain, physical comfort, physical independence, psychological support and emotional state. Each item is rated from 0 (unfavorable) to 10 (favorable), with an overall score corresponding to the sum of the score obtained for each item, i.e. a score from 0 (no recovery) to 150 (full recovery).

    Time frame: From enrollement to the last H24 after surgery

Secondary outcomes

  1. Knee functional assessment

    Functional assessment of the knee with KOOS JR questionnaire

    Time frame: Hour 0

  2. Post operative pain

    Pain measured with a simple numeric scale

    Time frame: Hour 2

  3. Post operative pain

    Pain measured with a simple numeric scale

    Time frame: Hour 6

  4. Post operative pain

    Pain measured with a simple numeric scale

    Time frame: Hour 12

  5. First ambulation

    time between end of intervention and first ambulation

    Time frame: Hour 12

  6. Post operative pain

    Pain measured with a simple numeric scale

    Time frame: Hour 24

  7. Joint range of both knees

    Measurement of the joint range of both knees

    Time frame: Hour 24

  8. First ambulation

    time between end of intervention and first ambulation

    Time frame: Hour 24

  9. Post operative pain

    Pain measured with a simple numeric scale

    Time frame: Hour 48

  10. Quality of recovery

    Quality of recovery measured with QoR 15 questionnaire

    Time frame: Hour 48

  11. Opioid drug use

    Opioid drug use evaluation

    Time frame: Hour 48

  12. Non-opioid drug use

    Non-opioid drug use evaluation

    Time frame: Hour 48

  13. Joint range of both knees

    Measurement of the joint range of both knees

    Time frame: Hour 48

  14. First ambulation

    time between end of intervention and first ambulation

    Time frame: Hour 48

  15. Length of stay in the post-intervention monitoring room

    Length of stay in the post-intervention monitoring room

    Time frame: Hour 48

  16. Post operative pain

    Pain measured with a simple numeric scale

    Time frame: Month 1

  17. Joint range of both knees

    Measurement of the joint range of both knees

    Time frame: Month 1

  18. Length of hospitalisation

    Length of hospitalisation

    Time frame: Month 1

  19. Return to patient usual activities

    Time taken for the patient to return to their usual activities

    Time frame: Month 1

  20. Drug tolerance

    Drug tolerance

    Time frame: Month 1

  21. Patient comfort

    Patient comfort during loco-regional anesthesia

    Time frame: Hour 1

  22. Knee functional assessment

    Functional assessment of the knee with KOOS JR questionnaire

    Time frame: Month 1

07

Study locations

1 of 2 sites recruiting
08

References and documents

Publications

  • Elmaleh Y, Maupain O, Guessous K, Kattou F, Laurent R, Giral T, Garnier T, Delvaux B. Comparison of a four-nerve block protocol versus adductor canal block plus local infiltration analgesia for primary total knee arthroplasty in two French private hospitals: protocol for the multicentre randomised INCA trial. BMJ Open. 2026 Jul 21;16(7):e119093. doi: 10.1136/bmjopen-2026-119093. PubMed 42481203 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for May 2027, 12 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 12 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2025
First posted
Apr 9, 2025
StartActual
May 4, 2026
Primary completionEst.
May 2027
CompletionEst.
Jun 2027
Last update
Jun 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06920186
Responsible party
Sponsor
First posted
Apr 9, 2025
Start date
May 4, 2026
Primary completion
May 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Jun 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion